Airbnb co-founder Joe Gebbia is stepping down

Airbnb co-founder Joe Gebbia is stepping down


Joe Gebbia, co-founder of Airbnb and chairman of Airbnb.org, during South By Southwest (SXSW) festival in Austin, Texas, U.S., on Sunday, March 13, 2022.

Matthew Busch | Bloomberg | Getty Images

Airbnb co-founder Joe Gebbia announced Thursday he is stepping down from his role in the company.

The 40-year-old has been with the company since its inception in 2007 and will remain on the board of directors.

“After great consideration, I’ve decided to step back from my full-time operating role at Airbnb,” Gebbia said in a letter to employees. “The primary reason for this transition is that this is the only company I’ve ever helped build, and my brain is bursting with more ideas to bring to the world.”

This is a developing story. Please check back for updates.



Source

The cost to fly private is up as much as 20% with fuel prices soaring
Business

The cost to fly private is up as much as 20% with fuel prices soaring

A Gulfstream G-IV private jet on approach to Washington’s Reagan National Airport in Arlington, Virginia, June 12, 2024. J. David Ake | Getty Images As the Iran war pushes jet fuel prices higher, well-heeled travelers are facing hefty surcharges to fly private, sometimes on flights booked months prior, charter brokers and aviation insiders told CNBC. […]

Read More
United unveils basic Polaris business fare in premium cabin overhaul
Business

United unveils basic Polaris business fare in premium cabin overhaul

United Airlines new Polaris seat on one of its Boeing 787 Dreamliners Leslie Josephs/CNBC Does it matter where you sit if you’re sipping Champagne in first class? United Airlines is betting that for some travelers looking for luxury at a discount, it doesn’t. The carrier is launching new, cheaper tiers for its top-end Polaris and […]

Read More
Trump administration prepares up to 100% pharmaceutical tariffs on some imported drugs
Business

Trump administration prepares up to 100% pharmaceutical tariffs on some imported drugs

The Trump administration is preparing to impose new tariffs on branded drugs from pharmaceutical companies that have not struck landmark deals with the president to lower their U.S. drug prices, CNBC has learned.  Patented medications and their active ingredients would be hit with a 100% tariff, according to a draft of the document obtained by […]

Read More